Search filters

List of works by Giuseppe Alberto Palumbo

A physiological role for the neuropeptide luteinizing hormone-releasing hormone (LHRH) during the maturation of thymus gland function

scientific article published on 01 April 1990

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

scientific article

Alternation of epirubicin and mitoxantrone in CHOP-like regimens retains efficacy and reduces overall toxicity in elderly patients with high and intermediate grade non-Hodgkin lymphomas.

scientific article

Angiogenesis in chronic myeloproliferative diseases.

scientific article

Antitumor activity of bortezomib alone and in combination with TRAIL in human acute myeloid leukemia.

scientific article published on 21 August 2008

Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study

scientific article published on September 10, 2012

BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint.

scientific article published on 16 September 2011

Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis

scientific article published on 27 June 2017

Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.

scientific article published on 16 September 2012

Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study.

scientific article published on 27 April 2015

Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.

scientific article

CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.

scientific article

Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53

scientific article published on 18 February 2019

Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy.

scientific article published on 7 November 2014

Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML

scientific article published on 01 August 2010

Comparison of JAK2(V617F) -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology

scientific article

Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma

scientific article published on 28 October 2019

Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome

scientific article published on 22 August 2019

Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a lar

scientific article published on 05 June 2018

Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review

scientific article published on 30 May 2020

Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.

scientific article published on 17 September 2015

Effects of micronised microencapsulated ferric pyrophosphate supplementation in patients with advanced cancer and iron deficiency: a single-centre cohort pilot study

scientific article published on 18 February 2019

Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors

scientific article published on 05 May 2011

Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study

scientific article

Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis.

scientific article published in June 2001

Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up

scientific article

Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up

scientific article published on 20 December 2011

Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome

scientific article published on 28 September 2015

Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients.

scientific article published in April 2004

Evaluation of Taxol cytotoxicity on B-CLL cells in vitro

scientific article published on 01 June 1997

FcgammaRIIIA and FcgammaRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab

scientific article published on 01 August 2007

Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.

scientific article

Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)

scientific article published on 7 March 2016

Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.

scientific article published on 8 February 2011

Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma

scientific article published on 15 February 2019

Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients

scientific article published on 22 April 2020

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

scientific article published on 07 June 2019

Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib

scientific article published on 04 December 2018

In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside

scientific article published on 01 January 2000

In vitro sensitivity of B-CLL cells to fludarabine and interferons

scientific article published on 01 May 1995

Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide

scientific article published on 22 June 2017

Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations

scientific article published on 28 October 2018

Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells

scientific article published on 22 July 2020

Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myeloma

scientific article published on 07 November 2012

Iron toxicity - Its effect on the bone marrow

scientific article published on 13 April 2018

Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?

scientific article published on 25 October 2006

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project

scientific article published on 8 March 2018

Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity.

scientific article published in August 1989

M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.

scientific article published on April 2009

Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib

scientific article published on 07 November 2019

Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients

scientific article

Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives

scientific article published on 20 August 2019

Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells

scientific article published on 30 April 2020

Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes

scientific article published on 06 January 2021

Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies

scientific article published on 01 November 2019

Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib

scientific article

Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review

scientific article published in 2023

Multidrug resistance mechanisms in chronic lymphocytic leukaemia

scientific article published on 01 March 2002

Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.

scientific article

Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients.

scientific article

Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor

scientific article published on 01 February 1994

Neuroendocrine modulation of lymphocyte's activity during the physiological menstrual cycle

scientific article published on 01 September 1990

Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation.

scientific article

PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy.

scientific article published on 30 April 2018

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

scientific article published on 12 December 2017

Peptidergic modulation of immune system development: Role of luteinizing hormone-releasing hormone

article

Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.

scientific article

Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3

scientific article published on 19 July 2019

Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.

scientific article published on 14 February 2018

Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation

scientific article published on 14 March 2011

Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia.

scientific article

Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab

scientific article published on 01 July 2003

Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

scientific article published on 07 January 2021

Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients

scientific article published on 16 July 2018

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation

scientific article

Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients.

scientific article

Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.

scientific article published in January 2004

Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.

scientific article published on June 2010

TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma

scientific article published on 20 September 2019

The Role of Inflammation and Inflammasome in Myeloproliferative Disease

scientific article published on 22 July 2020

The Role of New Technologies in Myeloproliferative Neoplasms

scientific article published on 26 April 2019

The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma

scientific article

The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms

scientific article published on 01 June 2007

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.

scientific article

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib

scientific article published on 09 July 2018

Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice

scientific article published on 12 December 2019

Vascular endothelial growth factor polymorphisms in mantle cell lymphoma

scientific article published on 19 December 2009

α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload

article